Please use this identifier to cite or link to this item:
https://repository.monashhealth.org/monashhealthjspui/handle/1/29296
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Terry M.B. | en |
dc.contributor.author | Wong E.M. | en |
dc.contributor.author | Southey M.C. | en |
dc.date.accessioned | 2021-05-14T09:53:48Z | en |
dc.date.available | 2021-05-14T09:53:48Z | en |
dc.date.copyright | 2020 | en |
dc.date.created | 20200508 | en |
dc.date.issued | 2020-05-08 | en |
dc.identifier.citation | British Journal of Cancer. 122 (8) (pp 1133-1140), 2020. Date of Publication: 14 Apr 2020. | en |
dc.identifier.issn | 0007-0920 | en |
dc.identifier.uri | https://repository.monashhealth.org/monashhealthjspui/handle/1/29296 | en |
dc.description.abstract | Current risk prediction models estimate the probability of developing breast cancer over a defined period based on information such as family history, non-genetic breast cancer risk factors, genetic information from high and moderate risk breast cancer susceptibility genes and, over the past several years, polygenic risk scores (PRS) from more than 300 common variants. The inclusion of additional data such as PRS improves risk stratification, but it is anticipated that the inclusion of epigenetic marks could further improve model performance accuracy. Here, we present the case for including information on DNA methylation marks to improve the accuracy of these risk prediction models, and consider how this approach contrasts genetic information, as identifying DNA methylation marks associated with breast cancer risk differs inherently according to the source of DNA, approaches to the measurement of DNA methylation, and the timing of measurement. We highlight several DNA-methylation-specific challenges that should be considered when incorporating information on DNA methylation marks into risk prediction models, using BRCA1, a highly penetrant breast cancer susceptibility gene, as an example. Only after careful consideration of study design and DNA methylation measurement will prospective performance of the incorporation of information regarding DNA methylation marks into risk prediction models be valid.Copyright © 2020, The Author(s). | en |
dc.language | English | en |
dc.language | en | en |
dc.publisher | Springer Nature | en |
dc.relation.ispartof | British Journal of Cancer | en |
dc.subject.mesh | DNA methylation | - |
dc.subject.mesh | laboratory technique | - |
dc.subject.mesh | promoter region | - |
dc.subject.mesh | BRCA1 protein | - |
dc.subject.mesh | breast cancer | - |
dc.subject.mesh | cancer risk | - |
dc.title | Integrating DNA methylation measures to improve clinical risk assessment: are we there yet? The case of BRCA1 methylation marks to improve clinical risk assessment of breast cancer. | en |
dc.type | Review | en |
dc.identifier.affiliation | Monash University - School of Clinical Sciences at Monash Health | - |
dc.type.studyortrial | Review article (e.g. literature review, narrative review) | - |
dc.identifier.doi | http://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1038/s41416-019-0720-2 | - |
dc.publisher.place | United Kingdom | en |
dc.identifier.pubmedid | 32066913 [http://www.ncbi.nlm.nih.gov/pubmed/?term=32066913] | en |
dc.identifier.source | 2004283011 | en |
dc.identifier.institution | (Wong, Southey) Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia (Wong, Southey) Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia (Southey) Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia (Terry) Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States (Terry) Herbert Irving Comprehensive Cancer Center, Columbia University, New York, NY, United States | en |
dc.description.address | M.B. Terry, Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, United States. E-mail: mt146@columbia.edu | en |
dc.description.publicationstatus | Embase | en |
dc.rights.statement | Copyright 2020 Elsevier B.V., All rights reserved. | en |
dc.identifier.authoremail | Terry M.B.; mt146@columbia.edu | en |
dc.description.grant | Organization: (BCRF) *Breast Cancer Research Foundation* Organization No: 100001006 Country: United States | en |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.openairetype | Review | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.grantfulltext | none | - |
Appears in Collections: | Articles |
Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.